Professional Documents
Culture Documents
Drug Study Cushing Disease
Drug Study Cushing Disease
Pharmacologic
class:
Adrenal
Corticosteroid
Synthesis
Inhibitor
Dosage: 800mg
day 1 then 200mg
subsequently
Route of
Administration:
Oral
Drug Name Mechanism of Indication& Contraindication Common Side Nursing
Action Rationale Effect Consideration
Generic Name: Zinc inhibits Indication: Contraindicated No adverse -Instruct the
Zinc sulphate cAMP-induced, to patient with reaction was seen patient to take
chloride-dependent Helps your hypersensitivity on the patient the medication
Brand Name: fluid secretion by immune to the drug and its 1 hr or 2hrs
Zincate inhibiting component. -nausea after meal.
system and
basolateral -vomiting
metabolic
Therapeutic potassium (K) -cramps -Instruct the
Class: nutritional channels. Zinc also function -heartburn patient do not
supplements improves the -diarrhea crush or chew,
absorption of water Rationale: -rash best to
Pharmacological and electrolytes, swallow
Class: trace improves It is given to whole.
elements regeneration of the help fight
intestinal bacteria and -Instruct the
Dosage: 220mg epithelium, for diarrhea. patient to
Frequency: OD increases the levels Used for avoid milk,
Form: Tablet of brush border proper bran, grains, or
Route of enzymes, and cereals within
senses of
Administration: enhances the 2 hours of
Oral immune response, taste and taking this
allowing for a smell medicine.
better clearance of
the pathogens. -Monitor zinc
levels during
tratement
-Take aluminum
or magnesium
antacids 2 h
before or after
drug.
Drug Name Mechanism Indication Contraindication Common Side Nursing
of Action Effect Consideration
Generic Name: Inhibits HIV1 Indication: Contraindicated to No adverse -Instruct the
Lopinavir/ protease and patient with reaction was seen patient to avoid
Ritonavir prevents It is used for hypersensitivity to on the patient. consuming red
maturation of treatment and the drug and its yeast rice and St.
Brand Name: the infectious prevention of component. -Nausea and John’s wart
Kaletra virus opportunistic vomiting while taking the
infection -decreased drug.
Therapeutic Class: appetite
Antiretroviral Rationale: -dry mouth -Assess bowel
-tiredness pattern before,
Pharmacological It is given for -dizziness during treatment.
Class: treatment of -headache if severe
Protease Inhibitor Covid 19 -joint or muscle abdominal pain
pain with bleeding
Dosage: 400mg occurs, product
should be
Frequency: BID discontinued
- Teach patient to
take as
prescribed; if
dose is missed,
take as soon as
remembered up
to 1 hr before
next dose; do not
double dose